exendin (9-39) Report issue

Biologics Peptide Experimental
AACT MeSH PubChem

Active Ingredient History

NOW
  • Now

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: No
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Alternative names

ex-9 | exendin 3 (heloderma horridum), 1-de-l-histidine-2-de-l-serine-3-de-l-aspartic acid-4-deglycine-5-de-l-threonine-6-de-l-phenylalanine-7-de-l-threonine-8-de-l-serine- | exendin (9-39) | exendin 9-39 | exendin-(9-39) | exendin(9-39) | exendin(9-39) 1200 | exendin(9-39) 300 | exendin(9-39) 600 | exendin(9-39) 900 | exendin (9-39) amide | exendin(9-39)amide

Organizations (38)

Research & Development (38)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (24)

Approved Indications (1)


 

Obesity

Experimental Indications - Clinical Trial Phases 1-4 (24)


 

Alzheimer Disease (Phase 2)

Bariatric Surgery (Phase 2)

Cognitive Dysfunction (Phase 2)

Congenital Hyperinsulinism (Phase 1/Phase 2)

Diabetes Mellitus (Phase 1)

Diabetes Mellitus, Type 2 (Phase 4)

Digestive System Physiological Phenomena (Phase 1)

Drugs, Investigational (Phase 1)

Dyspepsia (Phase 2)

Enteral Nutrition (Phase 1)

Gastrectomy (Early Phase 1)

Gastric Bypass (Phase 1)

Gastric Emptying (Phase 1)

Gastrointestinal Hormones (Phase 1)

Gastrointestinal Motility (Phase 1)

Glucagon-Like Peptide 1 (Phase 1)

Healthy Volunteers (Phase 3)

Hyperglycemia (Phase 1)

Hyperinsulinism ()

Hypoglycemia (Phase 2)

Insulin Secretion (Phase 4)

Obesity (Phase 4)

Pancreatic Diseases (Phase 1)

Prediabetic State (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 52
  • # of Trial Organizations: 38

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue